We are live on ! Find out more
FA

Fagan Associates Portfolio holdings

AUM $813M
1-Year Est. Return 37.92%
This Fund
S&P 500
This Quarter Est. Return
+9.57%
1 Year Est. Return
+37.92%
3 Year Est. Return
+110.01%
5 Year Est. Return
+134.08%
10 Year Est. Return
+676.44%
AUM
$412M
AUM Growth
+$10.2M
Cap. Flow
-$19.9M
Cap. Flow %
-4.83%
Top 10 Hldgs %
44.76%
Holding
128
New
6
Increased
36
Reduced
52
Closed
16

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$9.82M
2
TGT icon
Target
TGT
+$5.67M
3
GFS icon
GlobalFoundries
GFS
+$3.61M
4
PFE icon
Pfizer
PFE
+$2.5M
5
ANGL icon
VanEck Fallen Angel High Yield Bond ETF
ANGL
+$2.27M

Sector Composition

Rank Sector Weight
1 Technology 24.54%
2 Consumer Discretionary 12.01%
3 Financials 9.85%
4 Communication Services 9.63%
5 Healthcare 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
76
PepsiCo
PEP
$192B
$631K 0.15%
3,408
-13
-0.4% -$2.43K
BNDX icon
77
Vanguard Total International Bond ETF
BNDX
$83B
$626K 0.15%
12,812
-113
-0.9% -$5.51K
MPT
78
Medical Properties Trust
MPT
$2.51B
$599K 0.15%
64,685
-588
-0.9% -$4.97K
BAB icon
79
Invesco Taxable Municipal Bond ETF
BAB
$1.01B
$582K 0.14%
21,923
-495
-2% -$13.2K
CNI icon
80
Canadian National Railway
CNI
$77.2B
$554K 0.13%
4,575
-10
-0.2% -$1.19K
KO icon
81
Coca-Cola
KO
$376B
$519K 0.13%
8,622
GE icon
82
GE Aerospace
GE
$374B
$492K 0.12%
5,610
MDY icon
83
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
$456K 0.11%
952
EW icon
84
Edwards Lifesciences
EW
$53.4B
$446K 0.11%
4,725
GILD icon
85
Gilead Sciences
GILD
$171B
$443K 0.11%
5,745
+600
+12% +$47.9K
CSX icon
86
CSX Corp
CSX
$92.9B
$414K 0.1%
12,131
UCON icon
87
First Trust Smith Unconstrained Bond ETF
UCON
$3.29B
$409K 0.1%
16,940
+1,150
+7% +$28K
XLY icon
88
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.5B
$399K 0.1%
4,698
-80
-2% -$6.13K
PG icon
89
Procter & Gamble
PG
$335B
$378K 0.09%
2,488
SCHW
90
Charles Schwab
SCHW
$190B
$347K 0.08%
6,118
+750
+14% +$39.3K
IVV icon
91
iShares Core S&P 500 ETF
IVV
$910B
$342K 0.08%
767
CAT icon
92
Caterpillar
CAT
$393B
$322K 0.08%
1,310
MCD icon
93
McDonald's
MCD
$193B
$321K 0.08%
1,077
MRNA icon
94
Moderna
MRNA
$25.4B
$315K 0.08%
2,595
+170
+7% +$22.7K
DE icon
95
Deere & Co
DE
$165B
$315K 0.08%
777
BMY icon
96
Bristol-Myers Squibb
BMY
$132B
$306K 0.07%
4,789
-75
-2% -$5.03K
VTI icon
97
Vanguard Morningstar Total Stock Market ETF
VTI
$696B
$302K 0.07%
1,371
-397
-22% -$82.8K
AXP icon
98
American Express
AXP
$232B
$289K 0.07%
1,660
-315
-16% -$50.8K
SO icon
99
Southern Company
SO
$107B
$282K 0.07%
4,011
MRK icon
100
Merck
MRK
$334B
$279K 0.07%
2,420
+68
+3% +$7.72K

Similar funds

Fagan Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Fagan Associates held 128 positions worth $412M, up 2.5% from $402M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Fagan Associates withdrew a net $19.9M in Q2 2023, closing 16 positions and reducing 52 holdings. Its most notable exit was Qualcomm, an estimated $9.82M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Fagan Associates opened a new position in Crane NXT worth $4.04M.

  • Fagan Associates's largest Q2 2023 buy was Crane NXT: 71,631 shares worth $4.04M.
  • Fagan Associates added most to UnitedHealth in Q2 2023, an estimated $1.31M increase.
  • Fagan Associates's biggest Q2 2023 reduction was Alphabet (Google) Class A, cutting an estimated $279K.
  • Fagan Associates fully exited Qualcomm in Q2 2023, selling an estimated $9.82M.
  • Fagan Associates's ten largest holdings make up 45% of its $412M portfolio in Q2 2023.
  • Fagan Associates opened 6 new positions and closed 16 in Q2 2023.
  • Fagan Associates's portfolio value rose 2.5% quarter-over-quarter to $412M.

Based on Fagan Associates's 13F filing for Q2 2023, filed 8 Aug 2023.